Adagio Medical ADGM 深 滬
等待開盤 09-08 09:30:00 美东时间
0.564
+0.023
+4.31%
華盛通- 最 高0.5899
- 今 開0.534
- 成交量 29.76万股
- 最 低 0.53
- 昨 收 0.5407
- 總市值 1252.67万
- 52周最高 2.582
- 市盈率 靜 --
- 換手率 1.34%
- 52周最低 0.363
- 委 比 96.08%
- 總股本 2221.05万
- 歷史最高 9.34
- 量 比 1.66
- 振 幅 11.08%
- 歷史最低 0.363
- 每 手 1
- 風險率 0.40%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Adagio Medical Holdings Q2 EPS $(0.30) Beats $(0.31) Estimate
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 14.29 percent increase over losses of $(0.35) per share from the same period last year.
08-11 20:34
Adagio Medical Stock Is Trending Overnight: Here's Why ADGM Jumped 22% After Hours
Adagio Medical Holdings, Inc. (NASDAQ:ADGM) shares are trending overnight after climbing 21.76% to $0.56 in Monday’s after-hours session after the company announced the first patient was successfully treated with its next-generation vCLAS Ultra ablation system under the Food and Drug Administration’...
08-04 13:58
美股大行评级 | 火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元
火爆！24家大行集体上调派拓网络目标价，最高370美元；大摩上调美光目标价从520美元升至1050美元；犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
LUCID CAPITAL MARKETS Initiates Coverage On Adagio Medical Holdings with Buy Rating, Announces Price Target of $3
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Adagio Medical Holdings (NASDAQ:ADGM) with a Buy rating and announces Price Target of $3.
06-04 01:52
Adagio Medical Submits PMA Application To FDA For vCLAS Ventricular Ablation System For Treatment Of Drug-Refractory, Recurrent, Sustained Monomorphic VT In Patients With Ischemic Or Non-Ischemic Structural Heart Disease
PMA Submission Supported by FULCRUM-VT Pivotal Trial Data — 209 Patients Across 20 Leading Centers; Breakthrough Device Designation Previously GrantedMarks the First-Ever PMA Submission for a Purpose-Built VT Ablation
05-21 20:05
Adagio Medical Holdings Q1 EPS $(0.31) Misses $(0.29) Estimate
Adagio Medical Holdings (NASDAQ:ADGM) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 39.22 percent increase over losses of $(0.51) per
05-12 20:11
Adagio Medical Heart Ablation System Shows 84% Freedom From Shock
Adagio Medical shares rise after vCLAS trial shows strong VT outcomes, reduced drug use, and lower readmissions ahead of FDA review.
04-27 19:55
This Cloudflare Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Wall Street analysts upgraded several stocks, including Cloudflare, Alector, ProPetro, and Atlas Energy. See their ratings and targets here.
04-16 01:53
美股大行评级 | 小摩上调Bloom Energy目标价从166美元升至231美元；目标价28美元！大摩、高盛等多家机构首予Janus Living(JAN)超配评级
今日重点评级关注：Ascendiant Capital：维持Banzai International"买入"评级，目标价从23美元升至24美元；Ascendiant Capital：维持Synergy CHC Corp."买入"评级，目标价从5美元升至5.5美元
04-15 11:31
Adagio Medical's FULCRUM-VT Trial Receives FDA's Investigational Device Exemption Approval To Evaluate Safety, Effectiveness Of vCLAS Ultra-Low Temperature Ablation Ventricular Ablation System To Treat Sustained Monomorphic Ventricular Tachycardia
Adagio Medical Holdings, Inc. (Nasdaq: ADGM) ("Adagio" or "the Company"), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that the U.S. Food and Drug
04-08 20:08
